Localization of Parkinson’s disease-associated LRRK2 in normal and pathological human brain
- 25 June 2007
- journal article
- Published by Elsevier BV in Brain Research
- Vol. 1155, 208-219
- https://doi.org/10.1016/j.brainres.2007.04.034
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicityHuman Molecular Genetics, 2007
- Lack of evidence for Lrrk2 in α‐synuclein pathological inclusionsAnnals of Neurology, 2006
- Expression and localization of Parkinson's disease‐associated leucine‐rich repeat kinase 2 in the mouse brainJournal of Neurochemistry, 2006
- LRRK2 protein is a component of lewy bodiesAnnals of Neurology, 2006
- Distribution of PINK1 and LRRK2 in rat and mouse brainJournal of Neurochemistry, 2006
- LRRK2 expression linked to dopamine‐innervated areasAnnals of Neurology, 2006
- LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brainEuropean Journal of Neuroscience, 2006
- The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activityHuman Molecular Genetics, 2005
- Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's DiseaseNeuron, 2004
- Relationship of Neuronal Nitric Oxide Synthase Immunoreactivity to GnRH Neurons in the Ovariectomized and Intact Female RatJournal of Neuroendocrinology, 1996